Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP536463.RAenv6-eGhf2p1o3MD0k69PXYxP3cvjR8uVXjJZAktLck130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP536463.RAenv6-eGhf2p1o3MD0k69PXYxP3cvjR8uVXjJZAktLck130_provenance.
• NP925391.RAtIEmTYAYQ2RweOT03AyevZKebWULwJWKL9ubnsA_cdU130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925391.RAtIEmTYAYQ2RweOT03AyevZKebWULwJWKL9ubnsA_cdU130_provenance.
• NP175298.RA7QPPdJDfXailHos4Va3vJp_ZTwPqvFGqfdlLQZ6sGsI130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP175298.RA7QPPdJDfXailHos4Va3vJp_ZTwPqvFGqfdlLQZ6sGsI130_provenance.
• NP279241.RA7ZHtR7aebPriEgKaoXa5HE2yNswhnjiXsbiLTR-pkM4130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP279241.RA7ZHtR7aebPriEgKaoXa5HE2yNswhnjiXsbiLTR-pkM4130_provenance.
• NP370234.RA9EhjUq01vsBw4uOnrfiNDAjcO7np9Ohk4alIdk_o4WI130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP370234.RA9EhjUq01vsBw4uOnrfiNDAjcO7np9Ohk4alIdk_o4WI130_provenance.
• NP365537.RAT2iOr_xlLxTkYzfOuHAR7556tlSx7bEtBSJ40YJ2ALE130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP365537.RAT2iOr_xlLxTkYzfOuHAR7556tlSx7bEtBSJ40YJ2ALE130_provenance.
• NP850540.RAoulkax3Vpt7JZaBVOfPGnqlRES4wcSD2IpQP7OCg01k130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP850540.RAoulkax3Vpt7JZaBVOfPGnqlRES4wcSD2IpQP7OCg01k130_provenance.
• NP733628.RAe1YaHVZ7G3K0mDhYwWeDqDRooebZ1823K4JDn58cUk4130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP733628.RAe1YaHVZ7G3K0mDhYwWeDqDRooebZ1823K4JDn58cUk4130_provenance.
• NP872397.RAZWBrpSjgkK-aeAbGKLvrunYwZm1O3gsY19jAQTEfroA130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP872397.RAZWBrpSjgkK-aeAbGKLvrunYwZm1O3gsY19jAQTEfroA130_provenance.
• NP627951.RAzY6GrpUiP42v_MjtcH-MerkdiXumRPvYCOatkUZIVhk130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP627951.RAzY6GrpUiP42v_MjtcH-MerkdiXumRPvYCOatkUZIVhk130_provenance.
• NP436851.RA7fc-1UKBvoPKivFSDQVy_tKBrVnmQhJTneI-Q4wiWqQ130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP436851.RA7fc-1UKBvoPKivFSDQVy_tKBrVnmQhJTneI-Q4wiWqQ130_provenance.
• NP221189.RAbwSsB612uwYldoY7esS8egeltjUtyhCBBKHO4Sc2l3g130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221189.RAbwSsB612uwYldoY7esS8egeltjUtyhCBBKHO4Sc2l3g130_provenance.
• NP732535.RAecL-rJTioBJ7kTsLxM2eG9UaEu7zD1xAwW4EZuQZV3Y130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732535.RAecL-rJTioBJ7kTsLxM2eG9UaEu7zD1xAwW4EZuQZV3Y130_provenance.
• NP853217.RA6sExgo9dQnDf8sfnwqHWJgCTJzhiDDrqMhB51DksFh8130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP853217.RA6sExgo9dQnDf8sfnwqHWJgCTJzhiDDrqMhB51DksFh8130_provenance.
• NP794073.RAW3AVkwehLdMszMxMs7003BcKfQHTIOPn2Upg7ol9_JI130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP794073.RAW3AVkwehLdMszMxMs7003BcKfQHTIOPn2Upg7ol9_JI130_provenance.
• NP900848.RAVraCxHkMf1EbMFgVUKMnktSPG-ZBJvPMOwa0srk0rbc130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900848.RAVraCxHkMf1EbMFgVUKMnktSPG-ZBJvPMOwa0srk0rbc130_provenance.
• NP602794.RAE7ub7q1qC8E62yNdhIY_QZ5D4aH_HgyrQCFrTI9PQSs130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP602794.RAE7ub7q1qC8E62yNdhIY_QZ5D4aH_HgyrQCFrTI9PQSs130_provenance.
• NP615878.RAUr7RDFqdUMWCahu98tw5z4iSqvI9WKvmcsZfG6X4a0o130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615878.RAUr7RDFqdUMWCahu98tw5z4iSqvI9WKvmcsZfG6X4a0o130_provenance.
• NP615882.RAQQMQDj7PD6vVHNbgHodWD9ZFE2QMsC_RO-qV-fN542Q130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615882.RAQQMQDj7PD6vVHNbgHodWD9ZFE2QMsC_RO-qV-fN542Q130_provenance.
• NP615885.RAUuQ8zhim9-sFQEPxfXdoedk5ReQnKEnTvlWbYZTZQns130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615885.RAUuQ8zhim9-sFQEPxfXdoedk5ReQnKEnTvlWbYZTZQns130_provenance.
• NP290223.RADHjHG24cIpgXFyJ35p_mSqo3yW7--A8hMvsaYj8NMJw130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP290223.RADHjHG24cIpgXFyJ35p_mSqo3yW7--A8hMvsaYj8NMJw130_provenance.
• NP615884.RAAYmEgRlFkAodtgl5VWbDDlB_QG7nhJMUaly3NuCfVUA130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615884.RAAYmEgRlFkAodtgl5VWbDDlB_QG7nhJMUaly3NuCfVUA130_provenance.
• NP390893.RAuP4cFtWROZ3RKxSmHfbP89ulwNKCJIjB2-gCmfsOgpg130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390893.RAuP4cFtWROZ3RKxSmHfbP89ulwNKCJIjB2-gCmfsOgpg130_provenance.
• NP586276.RArIsMOBohvd4qULn2E_VnSrgCoIOo1K9SN-q5B4EpUBc130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586276.RArIsMOBohvd4qULn2E_VnSrgCoIOo1K9SN-q5B4EpUBc130_provenance.
• NP921430.RAjOhNtBftjciDgEnTRn5p7ArW5MHfvOCutv4drexyG1E130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921430.RAjOhNtBftjciDgEnTRn5p7ArW5MHfvOCutv4drexyG1E130_provenance.
• NP615879.RAuTj90AOBKeQ3oklBSll8YZRBwmJ_7_j4PVlF_uI1IVw130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615879.RAuTj90AOBKeQ3oklBSll8YZRBwmJ_7_j4PVlF_uI1IVw130_provenance.
• NP615883.RAmlqSC4zZpwPxexx2p47bjjmzFUbsD01gNXTqPVDDxAY130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615883.RAmlqSC4zZpwPxexx2p47bjjmzFUbsD01gNXTqPVDDxAY130_provenance.
• NP309841.RA3eiSjo49w8C8kDlFsGg6sT0aUDRBHb2bpU1TPb2ZNQI130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309841.RA3eiSjo49w8C8kDlFsGg6sT0aUDRBHb2bpU1TPb2ZNQI130_provenance.
• NP992199.RAJ8AkEhaWOP-xJUpciiwgwjKpwgCT_TMnBrjp2VCf84E130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP992199.RAJ8AkEhaWOP-xJUpciiwgwjKpwgCT_TMnBrjp2VCf84E130_provenance.
• NP786361.RAEoJ7Yzyrp8PAKSaIEEefdy1kmINOByv_ZJJ4MiIT6_8130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP786361.RAEoJ7Yzyrp8PAKSaIEEefdy1kmINOByv_ZJJ4MiIT6_8130_provenance.
• NP615876.RA_Gl4pRNNJpCo-61kEVAMMdpXi0tgtn535PE_rTVqyVE130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615876.RA_Gl4pRNNJpCo-61kEVAMMdpXi0tgtn535PE_rTVqyVE130_provenance.
• NP615877.RAy9UJCjFUOTkYOlOE-uWR5tDubdAmg8Jqcs6EX44CyNc130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615877.RAy9UJCjFUOTkYOlOE-uWR5tDubdAmg8Jqcs6EX44CyNc130_provenance.
• NP615880.RA_l88_5SYUVITQ08UIp6yIwSG9etAZ8dKwbgM9AhtAdY130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615880.RA_l88_5SYUVITQ08UIp6yIwSG9etAZ8dKwbgM9AhtAdY130_provenance.
• NP615881.RAzewAEv79SsDJWzWyE4PUn2kgqW0xb0JI6akMGLItFJc130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615881.RAzewAEv79SsDJWzWyE4PUn2kgqW0xb0JI6akMGLItFJc130_provenance.
• NP615887.RA_yxv1c9viuKsfykO4CL2u0spm7FrU4ZbyovUL-bu5Iw130_assertion description "[PMN surface activation and inflammatory markers (i.e., CD14, TF, CD11b, and leukocyte alkaline phosphatase [LAP]) were all significantly higher in ET versus control subjects, with CD14 and LAP being the highest in the JAK2 mutation carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615887.RA_yxv1c9viuKsfykO4CL2u0spm7FrU4ZbyovUL-bu5Iw130_provenance.